SCHEMBL8652131

SCHEMBL8652131

NC(=O)OC(=O)CC[C@@H](N)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.59
ALOX15 P16050 1/20 0.59
BLM P54132 1/20 0.59
PMP22 Q01453 1/20 0.59
SLC1A1 P43005 2/20 0.56
GSR P00390 2/20 0.56
CYP1A2 P05177 2/20 0.56
GRM8 O00222 2/20 0.56
GRM6 O15303 2/20 0.56
GRM7 Q14831 2/20 0.56
GRM4 Q14833 2/20 0.56
GRIN2D O15399 1/20 0.56
GRIN3B O60391 1/20 0.56
GRIK1 P39086 1/20 0.56
GRM5 P41594 1/20 0.56
GRIA1 P42261 1/20 0.56
GRIA2 P42262 1/20 0.56
GRIA3 P42263 1/20 0.56
SLC1A3 P43003 1/20 0.56
SLC1A2 P43004 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8648790 1.00 KMT2A (0.59) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL27970765 0.87 SLC1A1 (0.60) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL7294293 0.87 SLC1A1 (0.60) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL28015254 0.87 SLC1A1 (0.60) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL28203156 0.87 SLC1A1 (0.60) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL27563225 0.85 SLC1A1 (0.58) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL2917216 0.85 SLC1A1 (0.58) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL7158243 0.85 GSR (0.58) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL4406473 0.84 KMT2A (0.55) KMT2AALOX15BLMPMP22SLC1A1
SCHEMBL5076321 0.83 GSR (0.56) KMT2AALOX15BLMPMP22SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5807688-A ANTIBODY DIRECTED ANZYME PRODRUG THERAPY ZENECA LIMITED (GB) 1998-09-15 US disclosed
EP-0745673-A2 Catalytic antibody regulated prodrug therapy ZENECA LIMITED (GB) 1996-12-04 EP disclosed